Clinical Trials Browser

Phase 2 × Cholangiocarcinoma × ARRY-334543 × Clear all

NCT02609958 2018-05-29

ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy

Phase 2 Completed

Gastrointestinal

Cholangiocarcinoma